Skip to content

Comparison Of Postoperative Analgesia Between Surgical Wound Site Infiltration and Ultrasound Guided Ilioinguinal Iliohypogastric Nerve Block Following Inguinal Hernia Repair

Comparison Of Postoperative Analgesic Efficacy Between Surgical Wound Site Infiltration and Ultrasound Guided Ilioinguinal Iliohypogastric Nerve Block Following Inguinal Hernia Repair Under Spinal Anaesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013712
Enrollment
50
Registered
2018-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Inguinal Hernia

Interventions

Intervention1: ilioinguinal iliohypogastric nerve block: using 10 ml of 0.25% Bupivacaine Control Intervention1: surgical wound site infiltration: using 10 ml of 0.25% Bupivacaine

Sponsors

Department of Anaesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and ASA 2 patients undergoing inguinal hernia repair under spinal anaesthesia

Exclusion criteria

Exclusion criteria: pregnant and lactating women history of drug allergy to bupivacaine, chronic pain bilateral inguinal hernia repair refusal to consent

Design outcomes

Primary

MeasureTime frame
1. comparison of postoperative analgesia using visual analogue pain scale 2.comparison of time to first request of morphine in hours 3. comparison of total 24 hours consumption of morphine Timepoint: 0,0.5,1,2,4,6,12,24 hours

Secondary

MeasureTime frame
1. comparison of vital signs 2. comparison nausea, vomiting, sedation using the four point categorical scale in the postoperative periodTimepoint: 0,0.5,1,2,4,6,12,24 hours

Countries

India

Contacts

Public ContactDr Paul O Raphael

Amala Institute of Medical Sciences

poloralph1965@gmail.com8281804916

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026